Form 4 for ELV Elevance Health
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001156039-22-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-03 | 2022-03-01 | ELV | Norwood Felicia F | EVP, Pres, GBD | A - Grant | $0.00 | +9,196 | 28.9K | +47% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELV | Norwood Felicia F | EVP, Pres, GBD | F - Tax | $452.83 | -4,014 | 19.7K | -17% | -$1.82M |
| D | 2022-03-03 | 2022-03-01 | ELV | Norwood Felicia F | EVP, Pres, GBD | A - Grant | $0.00 | +8,832 | 8,832 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | A | A | 2,215 | $0.00 | 21,903 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows: 738 shares each on 3/1/2023 and 3/1/2024, and 739 shares on 3/1/2025. |
| 2 | Common | Common Stock | 2022-03-01 | A | A | 6,981 | $0.00 | 28,884 | D | — | — | (F3) Represents performance based restricted share units. Restrictions lapse on 3/1/2022. |
| 3 | Common | Common Stock | 2022-03-02 | F | D | 446 | $463.49 | 28,438 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 4 | Common | Common Stock | 2022-03-01 | F | D | 3,568 | $451.50 | 19,688 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2022-03-01 | A | A | 8,832 | $0.00 | 8,832 | D | $451.50 · — to 2032-03-01 | 8,832 Common Stock | (F4) The option represents a right to purchase a total of 8,832 shares, and is exercisable in three annual installments of 2,944 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date. |